Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010

Affiliations

¹ National Influenza Centre, Accra, Ghana.
² Food and Drug Administration, Rockville, MA, USA.
³ Harvard School of Public Health, Boston, MA, USA.
⁴ Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
⁵ NAMRU-3, Cairo, Egypt.
⁶ Network of Expertise on Animal Influenzas(OFFLU) Steering Committee, Hereford, UK.
⁷ Imperial College School of Medicine at St Mary's, London, UK.
⁸ Therapeutic Goods Administration Laboratories, Symonston, Australia.
⁹ National Institute for Medical Research, London, UK.
¹⁰ Ministry of Public Health, Nonthaburi, Thailand.
¹¹ National Institutes of Health, Bethesda, MD, USA.
¹² Freelancer, Bethesda, MD, USA.
¹³ National Influenza Centre, Pune, India.
¹⁴ University of Michigan School of Public Health, AnnArbor, MI, USA.
¹⁵ Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.
¹⁶ WHO Collaborating Centre for Reference and Research on Influenza, Tokyo, Japan.
¹⁷ Freelancer, Stanley, UK.
¹⁸ World Health Organization(WHO), Geneva, Switzerland.
¹⁹ National Institute for Biological Standards and Control(NIBSC), PottersBar, UK.
²⁰ Health Protection Agency, London, UK.

WHO Writing Group et al. Influenza Other Respir Viruses. 2013 Sep.

. 2013 Sep;7 Suppl 2(Suppl 2):52-53.

doi: 10.1111/irv.12081.

¹ National Influenza Centre, Accra, Ghana.
² Food and Drug Administration, Rockville, MA, USA.
³ Harvard School of Public Health, Boston, MA, USA.
⁴ Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA.
⁵ NAMRU-3, Cairo, Egypt.
⁶ Network of Expertise on Animal Influenzas(OFFLU) Steering Committee, Hereford, UK.
⁷ Imperial College School of Medicine at St Mary's, London, UK.
⁸ Therapeutic Goods Administration Laboratories, Symonston, Australia.
⁹ National Institute for Medical Research, London, UK.
¹⁰ Ministry of Public Health, Nonthaburi, Thailand.
¹¹ National Institutes of Health, Bethesda, MD, USA.
¹² Freelancer, Bethesda, MD, USA.
¹³ National Influenza Centre, Pune, India.
¹⁴ University of Michigan School of Public Health, AnnArbor, MI, USA.
¹⁵ Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.
¹⁶ WHO Collaborating Centre for Reference and Research on Influenza, Tokyo, Japan.
¹⁷ Freelancer, Stanley, UK.
¹⁸ World Health Organization(WHO), Geneva, Switzerland.
¹⁹ National Institute for Biological Standards and Control(NIBSC), PottersBar, UK.
²⁰ Health Protection Agency, London, UK.

No abstract available

Keywords: WHO recommendations; influenza vaccine viruses; vaccine virus selection.

Conflict of interest statement

The authors have no potential conflicts to declare.

1. WHO Writing Group , Ampofo WK, Baylor N et al Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010. Influenza Other Respi Viruses 2012; 6:142–152, e1‐5. - PMC - PubMed